Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
9.05
0.10 (1.12%)
At close: Aug 15, 2025, 3:59 PM
9.24
2.10%
After-hours: Aug 15, 2025, 07:50 PM EDT
Avalo Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -46.22M | 73.01M | -35.13M | -7.96M | -36.22M | -142.88M | -31.54M | -33.19M | -24.77M | -29.56M | -41.66M | -51.04M | -71.63M | -75.75M | -84.38M | -80.82M | -76.89M | -73.06M |
Depreciation & Amortization | 371K | 270K | 169K | 144K | 151K | 159K | 158K | 150K | 143K | 132K | 166K | 426K | 847K | 1.27M | 1.66M | 1.9M | 1.87M | 1.84M |
Stock-Based Compensation | 10.71M | 8.46M | 5.85M | 3.72M | 2.83M | 3.25M | 3.48M | 3.54M | 3.32M | 3.1M | 7.55M | 8.6M | 9.63M | 12.04M | 8.17M | 7.72M | 7.41M | 7.12M |
Other Working Capital | 1.96M | 895K | -939K | -2.44M | -7.61M | -5.85M | -9.29M | -5.63M | -315K | -1.33M | 3.66M | 403K | -6.64M | -1.37M | 961K | 516.55K | 5.51M | 656.04K |
Other Non-Cash Items | -14.69M | -134.33M | -18.53M | -31.84M | 8.21M | 121.73M | 6.46M | 2.3M | 1.62M | 1.57M | 1.39M | 1.39M | 1.38M | 1.14M | -5.5M | -5.03M | -5.37M | -3.61M |
Deferred Income Tax | 124K | 115K | 114K | -9K | 13K | 13K | 14K | 31K | 28K | 27K | 28K | 2K | 6K | 10K | 22K | 206.59K | 650.36K | 195.87K |
Change in Working Capital | 2.78M | 1.45M | -612K | 85K | -6.14M | -8.98M | -9.24M | -4.69M | 361K | 3M | 4.77M | -288K | -3.16M | -7.36M | 2.84M | 2.39M | 3.11M | 8.92M |
Operating Cash Flow | -47.42M | -52.31M | -49.06M | -36.78M | -32.09M | -26.83M | -30.68M | -31.85M | -19.29M | -20.74M | -26.75M | -39.91M | -61.93M | -68.64M | -70.89M | -68.17M | -63.75M | -53.12M |
Capital Expenditures | n/a | n/a | n/a | -158K | -158K | n/a | -158K | -56K | -95K | -309K | -151K | -106K | -148K | -92K | -113K | -102K | -83.66K | -83.66K |
Cash Acquisitions | -356K | -356K | n/a | -25K | 331K | 331K | n/a | 25K | 25K | 25K | n/a | n/a | n/a | n/a | n/a | 12.45M | 12.45M | 12.45M |
Purchase of Investments | -70.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12,836.7B | -12,836.7B | -12,836.7B |
Sales Maturities Of Investments | -146K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12,836.7B | 12,836.7B | 12,836.7B |
Other Investing Acitivies | 146K | n/a | 356K | 514K | 514K | 356K | -158K | -316K | -316K | -158K | n/a | n/a | n/a | n/a | n/a | -12.84M | -12.84M | n/a |
Investing Cash Flow | -70.86M | n/a | 356K | 198K | 198K | 356K | -133K | -31K | -70K | -284K | -151K | -106K | -148K | -92K | -113K | -493.17K | -474.83K | 12.36M |
Debt Repayment | n/a | n/a | n/a | n/a | -15.24M | -15.24M | -15.24M | -15.24M | n/a | n/a | n/a | n/a | 13.29M | 13.29M | 13.29M | 13.29M | n/a | n/a |
Common Stock Repurchased | 40K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 366K | 366K | 366K | 366K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 54.93M | 54.97M | 47.95M | -19.76M | -7.49M | -12.95M | -5.93M | -5.88M | -5.88M | -14.76M | -14.76M | -14.73M | -14.73M | 21.29M | 21.47M | 21.59M | 21.59M | 279.15K |
Financial Cash Flow | 67.24M | 67.24M | 175.85M | 108.14M | 118.84M | 119.91M | 25.04M | 25.12M | 14.43M | -951K | -14.7M | -14.71M | 32.94M | 68.94M | 106.76M | 106.89M | 59.25M | 73.51M |
Net Cash Flow | -51.04M | 14.93M | 127.15M | 71.72M | 87.1M | 93.43M | -5.77M | -6.87M | -5.04M | -21.91M | -41.55M | -54.72M | -29.14M | 202K | 35.76M | 38.23M | -4.98M | 32.76M |
Free Cash Flow | -47.42M | -52.31M | -49.06M | -36.94M | -32.24M | -26.83M | -30.84M | -31.91M | -19.39M | -21.05M | -26.9M | -40.02M | -62.07M | -68.73M | -71M | -68.27M | -63.83M | -53.2M |